87 FR 150 pgs. 48029-48030 - Solicitation of Nominations for Appointment to the Safety and Occupational Health Study Section
Type: NOTICEVolume: 87Number: 150Pages: 48029 - 48030
Pages: 48029, 48030FR document: [FR Doc. 2022-16807 Filed 8-4-22; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Safety and Occupational Health Study Section
ACTION:
Notice.
SUMMARY:
The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the Safety and Occupational Health Study Section (SOHSS). The SOHSS consists of 20 experts in fields associated with occupational medicine and nursing, industrial hygiene, occupational safety and engineering, toxicology, chemistry, safety and health education, ergonomics, epidemiology, economic science, psychology, pulmonary pathology/physiology, and social science.
DATES:
Nominations for membership on the SOHSS must be received no later than September 1, 2022. Packages received after this time will not be considered for the current membership cycle.
ADDRESSES:
All nominations should be mailed to Dr. Michael Goldcamp, National Institute for Occupational Safety and Health, CDC, 1095 Willowdale Road, Morgantown, West Virginia 26506, or emailed (recommended) to MGoldcamp@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Michael Goldcamp, Ph.D., Scientific Review Officer, National Institute for Occupational Safety and Health, CDC, 1095 Willowdale Road, Morgantown, West Virginia 26506; Telephone: (304) 285-5951; Email: MGoldcamp@cdc.gov.
SUPPLEMENTARY INFORMATION:
[top] Nominations are being sought for
Selection of members is based on candidates' qualifications to contribute to the accomplishment of SOHSS objectives.
The U.S. Department of Health and Human Services (HHS) policy stipulates that committee membership be balanced in terms of points of view represented, and the Study Section's function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens and cannot be full-time employees of the U.S. Government. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. CDC reviews potential candidates for SOHSS membership each year and provides a slate of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in October 2023, or as soon as the HHS selection process is completed. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. Candidates should submit the following items:
Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address).
At least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency ( e.g., CDC, NIH, FDA).
Nominations may be submitted by the candidate or by the person/organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-16807 Filed 8-4-22; 8:45 am]
BILLING CODE 4163-18-P